INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Novartis (Sweden)
Täby, SueciaPublicaciones en colaboración con investigadores/as de Novartis (Sweden) (9)
2022
-
Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
Cancer research, Vol. 82, Núm. 6, pp. 1098-1109
2020
2019
-
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973
-
Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia
Leukemia Research, Vol. 85
2015
2014
2013
-
Phase Ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma
Journal of Clinical Oncology
2012
-
Target genes of Topoisomerase IIβ regulate neuronal survival and are defined by their chromatin state
Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Núm. 16
2008
-
The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells
British Journal of Haematology, Vol. 141, Núm. 4, pp. 470-482